US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.500
  • +0.230+7.03%
Close Mar 28 16:00 ET
  • 3.560
  • +0.060+1.71%
Post 20:01 ET
670.18MMarket Cap-9.21P/E (TTM)

About Arbutus Biopharma Company

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Company Profile

SymbolABUS
Company NameArbutus Biopharma
Listing DateJul 20, 2007
Founded2005
CEOMs. Lindsay Androski
MarketNASDAQ
Employees44
Fiscal Year Ends12-31
Address701 Veterans Circle
CityWarminster
ProvincePennsylvania
CountryUnited States of America
Zip Code18974
Phone1-267-469-0914

Company Executives

  • Name
  • Position
  • Salary
  • Lindsay Androski
  • Director, President and Chief Executive Officer
  • --
  • Karen Sims
  • Chief Medical Officer
  • --
  • J. Christopher Naftzger
  • General Counsel, Chief Compliance Officer and Secretary
  • --
  • David C. Hastings
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Michael J. Sofia,PhD
  • Chief Scientific Officer
  • 1.61M
  • Robert Alan Beardsley
  • Director
  • --
  • Matthew Gline
  • Director
  • --
  • Joseph Bishop
  • Director
  • --
  • Anuj Hasija
  • Director
  • --
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.